SHERIDAN, WYOMING – May 7, 2025 – Edwards Lifesciences (NYSE: EW) has announced its participation in the highly anticipated BofA Securities 2025 Health Care Conference, scheduled for Tuesday, May 13, 2025. The company's leadership, including CEO Bernard Zovighian and CFO Scott Ullem, will take part in a fireside chat at 10:40 a.m. Pacific Time. The discussion will be accessible to investors and healthcare professionals through a live webcast available on the Edwards Lifesciences investor relations website at http://ir.edwards.com. An archived version of the session will be accessible later in the day for those unable to attend the live event.
Strategic Insights into Edwards Lifesciences' Leadership
At this significant event, Bernard Zovighian, CEO of Edwards Lifesciences, will discuss the company’s latest developments and vision for the future of structural heart innovation. The discussion will be an opportunity for investors and industry leaders to gain valuable insights into the company’s growth strategies, its commitment to enhancing patient care, and its ongoing leadership in heart valve technology.
Scott Ullem, CFO, will also offer perspectives on Edwards Lifesciences’ financial performance and future outlook. Their participation in this event underscores the company's commitment to transparency and communication with investors, as well as its dedication to maintaining its leadership in the medical technology sector.
A Global Leader in Structural Heart Innovation
Edwards Lifesciences has long been recognized as the world leader in structural heart technologies. Driven by a passion to improve the lives of patients, the company is at the forefront of developing breakthrough solutions in heart valve therapies and critical care monitoring. Edwards Lifesciences works in close collaboration with clinicians and healthcare stakeholders, striving to deliver life-changing innovations to those who need them most.
With a patient-focused culture at the heart of its operations, Edwards Lifesciences continues to lead the way in transforming the landscape of heart disease treatment. The company’s innovations are not only setting new standards of care but are also making significant impacts in the global healthcare industry.
A Platform for Engaging with Key Stakeholders
The BofA Securities Health Care Conference serves as a key platform for Edwards Lifesciences to engage with a broad audience, including investors, analysts, and healthcare professionals. The fireside chat will cover topics of strategic relevance, including the company’s latest product innovations, market trends, and its approach to expanding its global footprint in the medical device industry.
As healthcare continues to evolve, events like these provide valuable opportunities for leaders in the industry to share their vision and insights, ensuring they remain at the forefront of developments that affect patient care and clinical outcomes worldwide.
Conclusion
Edwards Lifesciences' participation in the BofA Securities 2025 Health Care Conference is an important milestone in the company’s efforts to engage with stakeholders and showcase its ongoing innovations. Healthcare professionals, investors, and industry experts are encouraged to tune in for the live webcast and gain first-hand knowledge from the company's top executives.